克莱德
爆发
病变
队列
医学
内科学
生物
病理
系统发育学
基因
生物化学
作者
Takara Nishiyama,Fuminari Miura,Yong Dam Jeong,Naotoshi Nakamura,Hyeongki Park,Masahiro Ishikane,Shotaro Yamamoto,Noriko Iwamoto,Michiyo Suzuki,Ayana Sakurai,Kazuyuki Aihara,Koichi Watashi,William S. Hart,Robin N. Thompson,Yasuhiro Yasutomi,Norio Ohmagari,Placide Mbala Kingebeni,John W. Huggins,Shingo Iwami,Phillip R. Pittman
标识
DOI:10.1126/scitranslmed.ads4773
摘要
Coinciding with the global outbreak of clade IIb mpox virus (MPXV), the Democratic Republic of the Congo (DRC) recently experienced a rapid surge in mpox cases with clade I MPXV. On 14 August 2024, the World Health Organization declared the continued cross-border spread of this clade in Africa a public health emergency of international concern (PHEIC). Clade I MPXV is known to be more fatal than clade IIb, but its clinical characteristics and prognosis differ between patients. Here, we used mathematical modeling to quantify temporal changes in total lesion counts during clade I MPXV infections, using data from a large cohort of patients with mpox in the DRC from 2007 to 2011. We further analyzed individuals’ clinical data to explore predictive biomarkers of high lesion counts. Our analysis indicates that patients with clade I mpox can be stratified into two groups according to lesion severity and that viral load in peripheral blood at symptom onset may serve as a predictor for this classification [area under the curve (AUC) = 0.70]. Our estimates also suggest substantial individual heterogeneity in the time period during which patients have lesions, ranging from 20 to 65 days. Understanding the severity and duration of lesions in different patients, as characterized by our approach, may contribute to more tailored treatment strategies and control measures in ongoing clade I mpox outbreaks.
科研通智能强力驱动
Strongly Powered by AbleSci AI